Other Species / Isoforms
  NIPA (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

 HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
P4
____MAAPCEGQAFA
0 1
NIPA (human) ____MAAPCEGQAFA P4
NIPA (mouse) ____MAAtSEGPLFA T4-p
NIPA iso2 (mouse) ____MAATSEGPLFA T4
NIPA iso3 (mouse) ____MAATSEGPLFA T4
NIPA (rat) ____MAASCEGQLFA S4
NIPA (cow) ____MAAPSEGTSFT P4
S24-p
NWGAVVRsPEGtPQk
Upstream
0 63
Treatment
  • BI_4834
  • MLN8054
  • nocodazole
  • SII_angiotensin_2
NIPA (human) NWGAVVRsPEGtPQk S24-p
NIPA (mouse) TWGSVVRsPEGtPQK S24-p
NIPA iso2 (mouse) TWGSVVRSPEGTPQK S24
NIPA iso3 (mouse) TWGSVVRSPEGTPQK S24
NIPA (rat) TWGAVVRsPEGtPQK S24-p
NIPA (cow) NWSAVVRSPEGTPQK S24
T28-p
VVRsPEGtPQkIRQL
Upstream
0 44
Treatment
  • SII_angiotensin_2
NIPA (human) VVRsPEGtPQkIRQL T28-p
NIPA (mouse) VVRsPEGtPQKVREL T28-p
NIPA iso2 (mouse) VVRSPEGTPQKVREL T28
NIPA iso3 (mouse) VVRSPEGTPQKVREL T28
NIPA (rat) VVRsPEGtPQKVRQL T28-p
NIPA (cow) VVRSPEGTPQKVRQL T28
K31-ub
sPEGtPQkIRQLIDE
0 1
NIPA (human) sPEGtPQkIRQLIDE K31-ub
NIPA (mouse) sPEGtPQKVRELIDE K31
NIPA iso2 (mouse) SPEGTPQKVRELIDE K31
NIPA iso3 (mouse) SPEGTPQKVRELIDE K31
NIPA (rat) sPEGtPQKVRQLIDE K31
NIPA (cow) SPEGTPQKVRQLIDE K31
T52-p
GGVDAKDtsATsQsV
0 2
NIPA (human) GGVDAKDtsATsQsV T52-p
NIPA (mouse) GGTEPKDTAAtFQsV T52
NIPA iso2 (mouse) GGTEPKDTAATFQSV T52
NIPA iso3 (mouse) GGTEPKDTAATFQSV T52
NIPA (rat) GGTEPKDTSATFQSV T52
NIPA (cow) GGAEAKDTSATFQSV T52
S53-p
GVDAKDtsATsQsVN
0 3
NIPA (human) GVDAKDtsATsQsVN S53-p
NIPA (mouse) GTEPKDTAAtFQsVD A53
NIPA iso2 (mouse) GTEPKDTAATFQSVD A53
NIPA iso3 (mouse) GTEPKDTAATFQSVD A53
NIPA (rat) GTEPKDTSATFQSVD S53
NIPA (cow) GAEAKDTSATFQSVN S53
T55
DAKDtsATsQsVNGs
0 1
NIPA (human) DAKDtsATsQsVNGs T55
NIPA (mouse) EPKDTAAtFQsVDGs T55-p
NIPA iso2 (mouse) EPKDTAATFQSVDGS T55
NIPA iso3 (mouse) EPKDTAATFQSVDGS T55
NIPA (rat) EPKDTSATFQSVDGs T55
NIPA (cow) EAKDTSATFQSVNGS T55
S56-p
AKDtsATsQsVNGsP
0 2
NIPA (human) AKDtsATsQsVNGsP S56-p
NIPA (mouse) PKDTAAtFQsVDGsP F56
NIPA iso2 (mouse) PKDTAATFQSVDGSP F56
NIPA iso3 (mouse) PKDTAATFQSVDGSP F56
NIPA (rat) PKDTSATFQSVDGsP F56
NIPA (cow) AKDTSATFQSVNGSP F56
S58-p
DtsATsQsVNGsPQA
Upstream
0 20
Treatment
  • BI2536
  • MLN8054
NIPA (human) DtsATsQsVNGsPQA S58-p
NIPA (mouse) DTAAtFQsVDGsPQA S58-p
NIPA iso2 (mouse) DTAATFQSVDGSPQA S58
NIPA iso3 (mouse) DTAATFQSVDGSPQA S58
NIPA (rat) DTSATFQSVDGsPQA S58
NIPA (cow) DTSATFQSVNGSPQA S58
S62-p
TsQsVNGsPQAEQPS
Upstream
0 52
Treatment
  • BI2536
  • MLN8054
  • nocodazole
NIPA (human) TsQsVNGsPQAEQPS S62-p
NIPA (mouse) tFQsVDGsPQAEQsP S62-p
NIPA iso2 (mouse) TFQSVDGSPQAEQSP S62
NIPA iso3 (mouse) TFQSVDGSPQAEQSP S62
NIPA (rat) TFQSVDGsPQAEQPP S62-p
NIPA (cow) TFQSVNGSPQAEEPP S62
P68
GsPQAEQPSLESTSk
0 5
NIPA (human) GsPQAEQPSLESTSk P68
NIPA (mouse) GsPQAEQsPLESTSK S68-p
NIPA iso2 (mouse) GSPQAEQSPLESTSK S68
NIPA iso3 (mouse) GSPQAEQSPLESTSK S68
NIPA (rat) GsPQAEQPPLESTSK P68
NIPA (cow) GSPQAEEPPLESTSK P68
K75-ub
PSLESTSkEAFFSRV
0 1
NIPA (human) PSLESTSkEAFFSRV K75-ub
NIPA (mouse) sPLESTSKEAFFHRV K75
NIPA iso2 (mouse) SPLESTSKEAFFHRV K75
NIPA iso3 (mouse) SPLESTSKEAFFHRV K75
NIPA (rat) PPLESTSKEAFFHRV K75
NIPA (cow) PPLESTSKEAFFSRV K75
T84-p
AFFSRVEtFSsLkWA
Upstream
0 2
Kinase, in vitro:
  • Chk1 (human)
NIPA (human) AFFSRVEtFSsLkWA T84-p
NIPA (mouse) AFFHRVETFSSLKWA T84
NIPA iso2 (mouse) AFFHRVETFSSLKWA T84
NIPA iso3 (mouse) AFFHRVETFSSLKWA T84
NIPA (rat) AFFHRVETFSSLKWA T84
NIPA (cow) AFFSRVETYSSLKWA T84
S87-p
SRVEtFSsLkWAGkP
0 3
NIPA (human) SRVEtFSsLkWAGkP S87-p
NIPA (mouse) HRVETFSSLKWAGKP S87
NIPA iso2 (mouse) HRVETFSSLKWAGKP S87
NIPA iso3 (mouse) HRVETFSSLKWAGKP S87
NIPA (rat) HRVETFSSLKWAGKP S87
NIPA (cow) SRVETYSSLKWAGKP S87
K89-ub
VEtFSsLkWAGkPFE
0 1
NIPA (human) VEtFSsLkWAGkPFE K89-ub
NIPA (mouse) VETFSSLKWAGKPPE K89
NIPA iso2 (mouse) VETFSSLKWAGKPPE K89
NIPA iso3 (mouse) VETFSSLKWAGKPPE K89
NIPA (rat) VETFSSLKWAGKPPE K89
NIPA (cow) VETYSSLKWAGKPSE K89
K93-ub
SsLkWAGkPFELsPL
0 2
NIPA (human) SsLkWAGkPFELsPL K93-ub
NIPA (mouse) SSLKWAGKPPELsPL K93
NIPA iso2 (mouse) SSLKWAGKPPELSPL K93
NIPA iso3 (mouse) SSLKWAGKPPELSPL K93
NIPA (rat) SSLKWAGKPPELSPL K93
NIPA (cow) SSLKWAGKPSELSPL K93
S98-p
AGkPFELsPLVCAKY
0 3
NIPA (human) AGkPFELsPLVCAKY S98-p
NIPA (mouse) AGKPPELsPLICAKY S98-p
NIPA iso2 (mouse) AGKPPELSPLICAKY S98
NIPA iso3 (mouse) AGKPPELSPLICAKY S98
NIPA (rat) AGKPPELSPLICAKY S98
NIPA (cow) AGKPSELSPLVCAKY S98
S161-p
KFCFWPDsPsPDRFG
0 6
NIPA (human) KFCFWPDsPsPDRFG S161-p
NIPA (mouse) KFCFWPDSPSPDRFG S161
NIPA iso2 (mouse) KFCFWPDSPSPDRFG S161
NIPA iso3 (mouse) KFCFWPDSPSPDRFG S161
NIPA (rat) KFCFWPDSPSPDRFG S161
NIPA (cow) KFCFWPDSPSPDRFG S161
S163-p
CFWPDsPsPDRFGML
0 1
NIPA (human) CFWPDsPsPDRFGML S163-p
NIPA (mouse) CFWPDSPSPDRFGML S163
NIPA iso2 (mouse) CFWPDSPSPDRFGML S163
NIPA iso3 (mouse) CFWPDSPSPDRFGML S163
NIPA (rat) CFWPDSPSPDRFGML S163
NIPA (cow) CFWPDSPSPDRFGML S163
S321-p
RLPLVPEsPRRMMTR
Upstream
0 49
Treatment
  • dasatinib
  • ischemia
  • nocodazole
NIPA (human) RLPLVPEsPRRMMTR S321-p
NIPA (mouse) HFPLVPESPRRMMTR S320
NIPA iso2 (mouse) HFPLVPESPRRMMTR S320
NIPA iso3 (mouse) HFPLVPESPRRMMTR S320
NIPA (rat) HFPLVPESPRRMMTR S320
NIPA (cow) RSPLVPESPRRMVTR S321
S329-p
PRRMMTRsQDAtFsP
Upstream
0 13
Treatment
  • AZD1152
  • BI2536
  • ZM447439
NIPA (human) PRRMMTRsQDAtFsP S329-p
NIPA (mouse) PRRMMTRsQDAtVsP S328-p
NIPA iso2 (mouse) PRRMMTRSQDATVSP S328
NIPA iso3 (mouse) PRRMMTRsQDATVSP S328-p
NIPA (rat) PRRMMTRSQDAAVsP S328
NIPA (cow) PRRMVTRSQDTIFSP S329
T333-p
MTRsQDAtFsPGsEQ
Upstream
0 10
Treatment
  • BI2536
  • MLN8054
NIPA (human) MTRsQDAtFsPGsEQ T333-p
NIPA (mouse) MTRsQDAtVsPGsEQ T332-p
NIPA iso2 (mouse) MTRSQDATVSPGSEQ T332
NIPA iso3 (mouse) MTRsQDATVSPGSEQ T332
NIPA (rat) MTRSQDAAVsPSSEQ A332
NIPA (cow) VTRSQDTIFSPGSEQ I333
S335-p
RsQDAtFsPGsEQAE
Upstream
0 51
Regulatory protein:
  • PRP4 (human)
Treatment
  • anti-CD3
  • AZD1152
  • BI2536
  • lapatinib
  • nocodazole
  • ZM447439
NIPA (human) RsQDAtFsPGsEQAE S335-p
NIPA (mouse) RsQDAtVsPGsEQsE S334-p
NIPA iso2 (mouse) RSQDATVSPGSEQSE S334
NIPA iso3 (mouse) RsQDATVSPGSEQDT S334
NIPA (rat) RSQDAAVsPSSEQsE S334-p
NIPA (cow) RSQDTIFSPGSEQAE S335
S338-p
DAtFsPGsEQAEKsP
Upstream
1 27
Regulatory protein:
  • PRKD1 (human)
Treatment
  • lapatinib
NIPA (human) DAtFsPGsEQAEKsP S338-p
NIPA (mouse) DAtVsPGsEQsEKsP S337-p
NIPA iso2 (mouse) DATVSPGSEQSEKSP S337
NIPA iso3 (mouse) DATVSPGSEQDTSPR S337
NIPA (rat) DAAVsPSSEQsEKsP S337
NIPA (cow) DTIFSPGSEQAEKSP S338
A341
FsPGsEQAEKsPGPI
0 5
NIPA (human) FsPGsEQAEKsPGPI A341
NIPA (mouse) VsPGsEQsEKsPGPI S340-p
NIPA iso2 (mouse) VSPGSEQSEKSPGPI S340
NIPA iso3 (mouse) gap -
NIPA (rat) VsPSSEQsEKsPGPI S340-p
NIPA (cow) FSPGSEQAEKSPGPI A341
S344-p
GsEQAEKsPGPIVsR
Upstream
1 77
Treatment
  • angiotensin-(1-7)
  • angiotensin_2
  • anti-CD3
  • AZD1152
  • BI2536
  • EGF
  • ischemia
  • lapatinib
  • metastatic potential
  • nocodazole
  • ZM447439
NIPA (human) GsEQAEKsPGPIVsR S344-p
NIPA (mouse) GsEQsEKsPGPIVsR S343-p
NIPA iso2 (mouse) GSEQSEKSPGPIVSR S343
NIPA iso3 (mouse) gap -
NIPA (rat) SSEQsEKsPGPIVSR S343-p
NIPA (cow) GSEQAEKSPGPIVSR S344
S350-p
KsPGPIVsRtRsWDs
0 8
NIPA (human) KsPGPIVsRtRsWDs S350-p
NIPA (mouse) KsPGPIVsRtRsWEs S349-p
NIPA iso2 (mouse) KSPGPIVSRTRSWES S349
NIPA iso3 (mouse) gap -
NIPA (rat) KsPGPIVSRtRsWES S349
NIPA (cow) KSPGPIVSRTRSGDS S350
T352-p
PGPIVsRtRsWDsss
0 7
NIPA (human) PGPIVsRtRsWDsss T352-p
NIPA (mouse) PGPIVsRtRsWEsss T351-p
NIPA iso2 (mouse) PGPIVSRTRSWESSS T351
NIPA iso3 (mouse) gap -
NIPA (rat) PGPIVSRtRsWESSs T351-p
NIPA (cow) PGPIVSRTRSGDSSS T352
S354-p
PIVsRtRsWDsssPV
Upstream
Downstream
4 70
Effects on Modified Protein
  • molecular association, regulation
Effects on Biological Processes:
  • apoptosis, altered
  • cell cycle regulation
Regulatory protein:
  • ALK (human)
  • TBK1 (human)
Treatment
  • angiotensin_2
  • EGF
  • selumetinib
  • SII_angiotensin_2
  • U0126
  • vemurafenib
NIPA (human) PIVsRtRsWDsssPV S354-p
NIPA (mouse) PIVsRtRsWEsssPV S353-p
NIPA iso2 (mouse) PIVSRTRSWESSSPV S353
NIPA iso3 (mouse) gap -
NIPA (rat) PIVSRtRsWESSsPV S353-p
NIPA (cow) PIVSRTRSGDSSSPV S354
S357-p
sRtRsWDsssPVDrP
0 8
NIPA (human) sRtRsWDsssPVDrP S357-p
NIPA (mouse) sRtRsWEsssPVDRP S356-p
NIPA iso2 (mouse) SRTRSWESSSPVDRP S356
NIPA iso3 (mouse) gap -
NIPA (rat) SRtRsWESSsPVDRP S356
NIPA (cow) SRTRSGDSSSPVDRP S357
S358-p
RtRsWDsssPVDrPE
0 9
NIPA (human) RtRsWDsssPVDrPE S358-p
NIPA (mouse) RtRsWEsssPVDRPE S357-p
NIPA iso2 (mouse) RTRSWESSSPVDRPE S357
NIPA iso3 (mouse) gap -
NIPA (rat) RtRsWESSsPVDRPE S357
NIPA (cow) RTRSGDSSSPVDRPE S358
S359-p
tRsWDsssPVDrPEP
Upstream
Downstream
2 33
Effects on Modified Protein
  • molecular association, regulation
Effects on Biological Processes:
  • cell cycle regulation
Treatment
  • anti-CD3
NIPA (human) tRsWDsssPVDrPEP S359-p
NIPA (mouse) tRsWEsssPVDRPEL S358-p
NIPA iso2 (mouse) TRSWESSSPVDRPEL S358
NIPA iso3 (mouse) gap -
NIPA (rat) tRsWESSsPVDRPEL S358-p
NIPA (cow) TRSGDSSSPVDRPEL S359
R363-m1
DsssPVDrPEPEAAs
0 1
NIPA (human) DsssPVDrPEPEAAs R363-m1
NIPA (mouse) EsssPVDRPELEAAs R362
NIPA iso2 (mouse) ESSSPVDRPELEAAS R362
NIPA iso3 (mouse) gap -
NIPA (rat) ESSsPVDRPELEAAs R362
NIPA (cow) DSSSPVDRPELEAAS R363
S370-p
rPEPEAAsPttRTRP
Upstream
2 51
Regulatory protein:
  • PRKD1 (human)
Treatment
  • anti-CD3
  • BI2536
  • BI_4834
  • dasatinib
  • SII_angiotensin_2
NIPA (human) rPEPEAAsPttRTRP S370-p
NIPA (mouse) RPELEAAsPTTRSRP S369-p
NIPA iso2 (mouse) RPELEAASPTTRSRP S369
NIPA iso3 (mouse) gap -
NIPA (rat) RPELEAAsPTtRSRP S369-p
NIPA (cow) RPELEAASPATRTRP S370
T372-p
EPEAAsPttRTRPVT
0 2
NIPA (human) EPEAAsPttRTRPVT T372-p
NIPA (mouse) ELEAAsPTTRSRPVT T371
NIPA iso2 (mouse) ELEAASPTTRSRPVT T371
NIPA iso3 (mouse) gap -
NIPA (rat) ELEAAsPTtRSRPVT T371
NIPA (cow) ELEAASPATRTRPVT A372
T373-p
PEAAsPttRTRPVTR
0 3
NIPA (human) PEAAsPttRTRPVTR T373-p
NIPA (mouse) LEAAsPTTRSRPVTR T372
NIPA iso2 (mouse) LEAASPTTRSRPVTR T372
NIPA iso3 (mouse) gap -
NIPA (rat) LEAAsPTtRSRPVTR T372-p
NIPA (cow) LEAASPATRTRPVTR T373
S381-p
RTRPVTRsMGtGDtP
1 9
NIPA (human) RTRPVTRsMGtGDtP S381-p
NIPA (mouse) RSRPVTRsMGtGDSA S380-p
NIPA iso2 (mouse) RSRPVTRSMGTGDSA S380
NIPA iso3 (mouse) gap -
NIPA (rat) RSRPVTRSMGTGDSA S380
NIPA (cow) RTRPVTRSMGTGDSA S381
T384-p
PVTRsMGtGDtPGLE
0 7
NIPA (human) PVTRsMGtGDtPGLE T384-p
NIPA (mouse) PVTRsMGtGDSAGVE T383-p
NIPA iso2 (mouse) PVTRSMGTGDSAGVE T383
NIPA iso3 (mouse) gap -
NIPA (rat) PVTRSMGTGDSAGLE T383
NIPA (cow) PVTRSMGTGDSAGLE T384
T387-p
RsMGtGDtPGLEVPs
1 21
NIPA (human) RsMGtGDtPGLEVPs T387-p
NIPA (mouse) RsMGtGDSAGVEVPs S386
NIPA iso2 (mouse) RSMGTGDSAGVEVPS S386
NIPA iso3 (mouse) gap -
NIPA (rat) RSMGTGDSAGLEVPs S386
NIPA (cow) RSMGTGDSAGLEVPS S387
S394-p
tPGLEVPssPLRKAK
0 20
NIPA (human) tPGLEVPssPLRKAK S394-p
NIPA (mouse) SAGVEVPssPLRRTK S393-p
NIPA iso2 (mouse) SAGVEVPSSPLRRTK S393
NIPA iso3 (mouse) gap -
NIPA (rat) SAGLEVPssPHRRAK S393-p
NIPA (cow) SAGLEVPSSPLRKAK S394
S395-p
PGLEVPssPLRKAKR
Upstream
Downstream
2 74
Effects on Modified Protein
  • activity, inhibited
  • molecular association, regulation
Effects on Biological Processes:
  • cell cycle regulation
Kinase, in vitro:
  • CDK1 (human)
Treatment
  • anti-CD3
  • ischemia
  • metastatic potential
  • nocodazole
NIPA (human) PGLEVPssPLRKAKR S395-p
NIPA (mouse) AGVEVPssPLRRTKR S394-p
NIPA iso2 (mouse) AGVEVPSSPLRRTKR S394
NIPA iso3 (mouse) gap -
NIPA (rat) AGLEVPssPHRRAKR S394-p
NIPA (cow) AGLEVPSSPLRKAKR S395
S407-p
AKRARLCsssssDts
Upstream
0 535
Treatment
  • angiotensin_2
  • gefitinib
  • imatinib
  • ischemia
  • selumetinib
  • SII_angiotensin_2
  • Su11274
  • U0126
  • vemurafenib
NIPA (human) AKRARLCsssssDts S407-p
NIPA (mouse) TKRARLCsssssDts S406-p
NIPA iso2 (mouse) TKRARLCSSSSSDTS S406
NIPA iso3 (mouse) gap -
NIPA (rat) AKRPRLCsSSsSDTS S406-p
NIPA (cow) AKRARLCsSSSLDAS S407-p
S408-p
KRARLCsssssDtss
0 55
NIPA (human) KRARLCsssssDtss S408-p
NIPA (mouse) KRARLCsssssDtsP S407-p
NIPA iso2 (mouse) KRARLCSSSSSDTSP S407
NIPA iso3 (mouse) gap -
NIPA (rat) KRPRLCsSSsSDTSP S407
NIPA (cow) KRARLCsSSSLDASS S408
S409-p
RARLCsssssDtssR
0 59
NIPA (human) RARLCsssssDtssR S409-p
NIPA (mouse) RARLCsssssDtsPR S408-p
NIPA iso2 (mouse) RARLCSSSSSDTSPR S408
NIPA iso3 (mouse) gap -
NIPA (rat) RPRLCsSSsSDTSPR S408
NIPA (cow) RARLCsSSSLDASSR S409
S410-p
ARLCsssssDtssRs
Upstream
0 145
Treatment
  • angiotensin_2
  • imatinib
  • SII_angiotensin_2
  • Su11274
  • U0126
NIPA (human) ARLCsssssDtssRs S410-p
NIPA (mouse) ARLCsssssDtsPRS S409-p
NIPA iso2 (mouse) ARLCSSSSSDTSPRS S409
NIPA iso3 (mouse) gap -
NIPA (rat) PRLCsSSsSDTSPRS S409-p
NIPA (cow) ARLCsSSSLDASSRS S410
S411-p
RLCsssssDtssRsF
Upstream
0 146
Treatment
  • imatinib
  • Su11274
  • U0126
NIPA (human) RLCsssssDtssRsF S411-p
NIPA (mouse) RLCsssssDtsPRSF S410-p
NIPA iso2 (mouse) RLCSSSSSDTSPRSF S410
NIPA iso3 (mouse) gap -
NIPA (rat) RLCsSSsSDTSPRSF S410
NIPA (cow) RLCsSSSLDASSRSF L411
T413-p
CsssssDtssRsFFD
0 18
NIPA (human) CsssssDtssRsFFD T413-p
NIPA (mouse) CsssssDtsPRSFFD T412-p
NIPA iso2 (mouse) CSSSSSDTSPRSFFD T412
NIPA iso3 (mouse) SPGSEQDTSPRSFFD T341
NIPA (rat) CsSSsSDTSPRSFFD T412
NIPA (cow) CsSSSLDASSRSFFD A413
S414-p
sssssDtssRsFFDP
Upstream
0 5
Treatment
  • U0126
NIPA (human) sssssDtssRsFFDP S414-p
NIPA (mouse) sssssDtsPRSFFDP S413-p
NIPA iso2 (mouse) SSSSSDTSPRSFFDP S413
NIPA iso3 (mouse) PGSEQDTSPRSFFDP S342
NIPA (rat) sSSsSDTSPRSFFDP S413
NIPA (cow) sSSSLDASSRSFFDP S414
S415-p
ssssDtssRsFFDPT
0 4
NIPA (human) ssssDtssRsFFDPT S415-p
NIPA (mouse) ssssDtsPRSFFDPT P414
NIPA iso2 (mouse) SSSSDTSPRSFFDPT P414
NIPA iso3 (mouse) GSEQDTSPRSFFDPT P343
NIPA (rat) SSsSDTSPRSFFDPT P414
NIPA (cow) SSSLDASSRSFFDPT S415
S417-p
ssDtssRsFFDPTSQ
0 1
NIPA (human) ssDtssRsFFDPTSQ S417-p
NIPA (mouse) ssDtsPRSFFDPTSQ S416
NIPA iso2 (mouse) SSDTSPRSFFDPTSQ S416
NIPA iso3 (mouse) EQDTSPRSFFDPTsQ S345
NIPA (rat) sSDTSPRSFFDPTSQ S416
NIPA (cow) SLDASSRSFFDPTSQ S417
S423
RsFFDPTSQHRDWCP
0 1
NIPA (human) RsFFDPTSQHRDWCP S423
NIPA (mouse) RSFFDPTSQHRDWCP S422
NIPA iso2 (mouse) RSFFDPTSQHRDWCP S422
NIPA iso3 (mouse) RSFFDPTsQHRDWCP S351-p
NIPA (rat) RSFFDPTSQHRDWCP S422
NIPA (cow) RSFFDPTSQHRDWCP S423
S471-p
ILLAHKQssQPAEtD
0 2
NIPA (human) ILLAHKQssQPAEtD S471-p
NIPA (mouse) ILLAHKRSNQPAETD S470
NIPA iso2 (mouse) ILLAHKRSNQPAETD S470
NIPA iso3 (mouse) ILLAHKRSNQPAETD S399
NIPA (rat) ILLAHKHSNQPAETD S470
NIPA (cow) ILLAHKQSNQPAETN S471
S472-p
LLAHKQssQPAEtDs
0 2
NIPA (human) LLAHKQssQPAEtDs S472-p
NIPA (mouse) LLAHKRSNQPAETDS N471
NIPA iso2 (mouse) LLAHKRSNQPAETDS N471
NIPA iso3 (mouse) LLAHKRSNQPAETDS N400
NIPA (rat) LLAHKHSNQPAETDS N471
NIPA (cow) LLAHKQSNQPAETNS N472
T477-p
QssQPAEtDsMsLsE
0 2
NIPA (human) QssQPAEtDsMsLsE T477-p
NIPA (mouse) RSNQPAETDSMSLsE T476
NIPA iso2 (mouse) RSNQPAETDSMLK__ T476
NIPA iso3 (mouse) RSNQPAETDSMSLSE T405
NIPA (rat) HSNQPAETDSMSLSE T476
NIPA (cow) QSNQPAETNSMSLSE T477
S479-p
sQPAEtDsMsLsEks
0 3
NIPA (human) sQPAEtDsMsLsEks S479-p
NIPA (mouse) NQPAETDSMSLsEKS S478
NIPA iso2 (mouse) NQPAETDSMLK____ S478
NIPA iso3 (mouse) NQPAETDSMSLSEKS S407
NIPA (rat) NQPAETDSMSLSEKS S478
NIPA (cow) NQPAETNSMSLSEKS S479
S481-p
PAEtDsMsLsEksRK
0 1
NIPA (human) PAEtDsMsLsEksRK S481-p
NIPA (mouse) PAETDSMSLsEKSRK S480
NIPA iso2 (mouse) gap -
NIPA iso3 (mouse) PAETDSMSLSEKSRK S409
NIPA (rat) PAETDSMSLSEKSRK S480
NIPA (cow) PAETNSMSLSEKSRK S481
S483-p
EtDsMsLsEksRKVF
0 5
NIPA (human) EtDsMsLsEksRKVF S483-p
NIPA (mouse) ETDSMSLsEKSRKVF S482-p
NIPA iso2 (mouse) gap -
NIPA iso3 (mouse) ETDSMSLSEKSRKVF S411
NIPA (rat) ETDSMSLSEKSRKVF S482
NIPA (cow) ETNSMSLSEKSRKVF S483
K485-ub
DsMsLsEksRKVFRI
0 2
NIPA (human) DsMsLsEksRKVFRI K485-ub
NIPA (mouse) DSMSLsEKSRKVFRI K484
NIPA iso2 (mouse) gap -
NIPA iso3 (mouse) DSMSLSEKSRKVFRI K413
NIPA (rat) DSMSLSEKSRKVFRI K484
NIPA (cow) NSMSLSEKSRKVFRI K485
S486-p
sMsLsEksRKVFRIF
0 1
NIPA (human) sMsLsEksRKVFRIF S486-p
NIPA (mouse) SMSLsEKSRKVFRIF S485
NIPA iso2 (mouse) gap -
NIPA iso3 (mouse) SMSLSEKSRKVFRIF S414
NIPA (rat) SMSLSEKSRKVFRIF S485
NIPA (cow) SMSLSEKSRKVFRIF S486